Yumoto Y, Okuda T, Yoshida Y
Division of Hematology and Cancer Chemotherapy, Nagahama City Hospital, Shiga, Japan.
Rinsho Ketsueki. 1996 Mar;37(3):255-9.
Primary myelofibrosis was diagnosed in a 43-year-old female in 1991, who gradually became transfusion dependent. There was no evidence suggesting connective tissue diseases except for biological false positive STS. Because her direct Coombs' test was positive and serum haptoglobin level was extremely low (< 6mg/dl), intermediate dose (30mg/day) prednisolone therapy was started. Her hemoglobin level and platelet count increased dramatically to a normal level within 3 weeks after the initiation of prednisolone therapy. Bone marrow biopsy performed 6 months later revealed marked recovery of hematopoiesis. Though the effects of corticosteroid therapy in primary myelofibrosis still remain unclear, this therapy might be useful in the treatment of some groups of patients via the correction of immunological aberrations and/or the decrease of bone marrow fiber.
1991年,一名43岁女性被诊断为原发性骨髓纤维化,逐渐变得依赖输血。除了生物学假阳性梅毒血清试验外,没有证据表明存在结缔组织疾病。由于她的直接抗人球蛋白试验呈阳性,血清触珠蛋白水平极低(<6mg/dl),因此开始使用中等剂量(30mg/天)泼尼松龙治疗。泼尼松龙治疗开始后3周内,她的血红蛋白水平和血小板计数急剧上升至正常水平。6个月后进行的骨髓活检显示造血功能明显恢复。虽然皮质类固醇疗法对原发性骨髓纤维化的疗效仍不明确,但这种疗法可能通过纠正免疫异常和/或减少骨髓纤维,对某些患者群体的治疗有用。